Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer

被引：0
|
作者：
W Chua
D Goldstein
C K Lee
H Dhillon
M Michael
P Mitchell
S J Clarke
B Iacopetta
机构：
[1] Sydney Cancer Centre,Department of Medical Oncology
[2] Concord Repatriation General Hospital,Department of Medical Oncology
[3] Prince of Wales Hospital,Division of Haematology and Medical Oncology
[4] NHMRC Clinical Trials Centre,Department of Medical Oncology
[5] Centre of Medical Psychology and Evidence-based Decision-Making,undefined
[6] University of Sydney,undefined
[7] Peter MacCallum Cancer Centre,undefined
[8] Austin Hospital,undefined
[9] School of Surgery,undefined
[10] University of Western Australia,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
colorectal cancer; metastatic; chemotherapy; predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：998 / 1004
页数：6
相关论文
共 50 条
  • [1] Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
    Chua, W.
    Goldstein, D.
    Lee, C. K.
    Dhillon, H.
    Michael, M.
    Mitchell, P.
    Clarke, S. J.
    Iacopetta, B.
    BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 998 - 1004
  • [2] Molecular Markers of Chemotherapy Toxicity in Colorectal Cancer
    Braun, Michael S.
    Seymour, Matthew T.
    CURRENT COLORECTAL CANCER REPORTS, 2011, 7 (01) : 105 - 111
  • [3] Molecular Markers of Chemotherapy Response in Colorectal Cancer
    Braun, Michael S.
    Seymour, Matthew T.
    CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (03) : 118 - 125
  • [4] Molecular markers of chemotherapeutic response and toxicity in colorectal cancer
    Braun, Michael S.
    Quirke, Philip
    Seymour, Matthew T.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 489 - 501
  • [5] Molecular Markers Predictive of Chemotherapy Response in Colorectal Cancer
    Shiovitz S.
    Grady W.M.
    Current Gastroenterology Reports, 2015, 17 (2)
  • [6] Prediction of response to FOLFOX in metastatic colorectal cancer by mtTFA
    Yoshida, Y.
    Hasegawa, J.
    Nezu, R.
    Kim, Y.
    Hirota, M.
    Yoshikawa, K.
    Ohashi, H.
    Kawano, K.
    Izumi, H.
    Kohno, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Popliteal pseudoaneurysm after FOLFOX chemotherapy for metastatic colorectal cancer
    Cosic, Luka
    Theivendren, Mayo
    Spanger, Manfred
    Weinberg, Laurence
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2019, 63 : 1 - 4
  • [8] Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers
    Bignucolo, Alessia
    Scarabel, Lucia
    Toffoli, Giuseppe
    Cecchin, Erika
    De Mattia, Elena
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (06) : 689 - 713
  • [9] Molecular Markers in the Treatment of Metastatic Colorectal Cancer
    Wilson, Peter M.
    LaBonte, Melissa J.
    Lenz, Heinz-Josef
    CANCER JOURNAL, 2010, 16 (03): : 262 - 272
  • [10] Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients
    Cortejoso, Lucia
    Lopez-Fernandez, Luis A.
    PHARMACOGENOMICS, 2012, 13 (10) : 1173 - 1191
12345